Plasma Protein Therapeutics Market Competitive Landscape 2024-2033 – Major Players and Strategies

Overview and Scope

Plasma protein therapeutics refers to therapies derived from plasma and their recombinant analogs. It is used for the treatment of specific medical conditions by replacing missing or deficient proteins found in plasma, allowing recipients to live healthier and more productive lives.

Sizing and Forecast

The plasma protein therapeutics market size has grown strongly in recent years. It will grow from $29.66 billion in 2023 to $32.22 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increasing prevalence of rare diseases, growing aging population, global blood plasma supply, rise in hemophilia cases, improvements in diagnosis, supportive regulatory environment..

The plasma protein therapeutics market size is expected to see strong growth in the next few years. It will grow to $43.85 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to gene therapy advancements, increasing healthcare expenditure, expanded indications, precision medicine approaches, patient access programs.. Major trends in the forecast period include technological innovations, telemedicine adoption, technological advancements in plasma fractionation, development of next-generation therapies, adoption of recombinant therapies, personalized medicine approaches..

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

Segmentation & Regional Insights

The plasma protein therapeutics market covered in this report is segmented –

1) By Product: Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products
2) By Route Of Administration: Intravenous, Subcutaneous
3) By Applications: Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema, Other Applications

North America was the largest region in the plasma protein therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma protein therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9213&type=smp

Major Driver Impacting Market Growth

An increasing prevalence of autoimmune disorders is expected to propel the growth of the plasma protein therapeutics market going forward. An autoimmune disorder is a condition that emerges when the body’s immune system attacks and destroys healthy body cells. Therapeutic plasma exchange is used to treat autoimmune diseases, which emerge when the body misidentifies a part of itself as foreign and produces proteins (known as autoantibodies) that attack the part of the body that is misidentified. For instance, in September 2021, according to Scientific American, a US-based science magazine, autoimmune diseases affect about 4% of the global population. Therefore, the increasing prevalence of autoimmune disorders is driving the growth of the plasma protein therapeutics market going forward.

Key Industry Players

Major companies operating in the plasma protein therapeutic market are adopting strategic collaborations to gain a competitive edge in the market. Plasma protein therapeutic companies engage in strategic partnerships to enhance their product portfolios, expand their global reach, and drive innovation in the development of new therapies. For instance, in September 2022, LFB Plasma, a US-based plasma collection company, announced its association with the Plasma Protein Therapeutics Association (PPTA), a US-based manufacturer of plasma-derived and recombinant analog therapies, to continue its expansion in the US. This collaboration will help strengthen LFB Plasma’s commitment to plasma donors and patients alike.

The plasma protein therapeutics market report table of contents includes:

1. Executive Summary

2. Plasma Protein Therapeutics Market Characteristics

3. Plasma Protein Therapeutics Market Trends And Strategies

4. Plasma Protein Therapeutics Market – Macro Economic Scenario

5. Global Plasma Protein Therapeutics Market Size and Growth

…..

31. Global Plasma Protein Therapeutics Market Competitive Benchmarking

32. Global Plasma Protein Therapeutics Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Plasma Protein Therapeutics Market

34. Plasma Protein Therapeutics Market Future Outlook and Potential Analysis

35. Appendix